Immunovia AB (publ) (IMMNOV.ST)
- Previous Close
2.0000 - Open
2.0000 - Bid 2.0500 x --
- Ask 2.0900 x --
- Day's Range
1.9240 - 2.1750 - 52 Week Range
0.5140 - 4.9000 - Volume
1,008,622 - Avg. Volume
708,110 - Market Cap (intraday)
93.066M - Beta (5Y Monthly) 2.73
- PE Ratio (TTM)
-- - EPS (TTM)
-10.4400 - Earnings Date Apr 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Immunovia AB (publ), a diagnostic company, develops and commercializes blood-based diagnostics for cancer in Sweden and internationally. It offers IMMray PanCan-d, a blood-based test for the early detection of pancreatic cancer. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
www.immunovia.com11
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: IMMNOV.ST
Performance Overview: IMMNOV.ST
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IMMNOV.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IMMNOV.ST
Valuation Measures
Market Cap
93.07M
Enterprise Value
12.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
34.06
Price/Book (mrq)
1.00
Enterprise Value/Revenue
6.60
Enterprise Value/EBITDA
-0.07
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-92.88%
Return on Equity (ttm)
-199.13%
Revenue (ttm)
1.57M
Net Income Avi to Common (ttm)
-309.44M
Diluted EPS (ttm)
-10.4400
Balance Sheet and Cash Flow
Total Cash (mrq)
76.79M
Total Debt/Equity (mrq)
15.32%
Levered Free Cash Flow (ttm)
-48.74M
Company Insights: IMMNOV.ST
IMMNOV.ST does not have Company Insights